Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: RemeGen Co., Ltd.
Condition: Melanoma, Stage II, HER2-positive, Advanced Melanoma
NCT05135715
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.